308 related articles for article (PubMed ID: 22619522)
1. Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention.
Wang D; Taylor EW; Wang Y; Wan X; Zhang J
Int J Nanomedicine; 2012; 7():1711-21. PubMed ID: 22619522
[TBL] [Abstract][Full Text] [Related]
2. Nanochemoprevention: sustained release of bioactive food components for cancer prevention.
Siddiqui IA; Adhami VM; Ahmad N; Mukhtar H
Nutr Cancer; 2010; 62(7):883-90. PubMed ID: 20924964
[TBL] [Abstract][Full Text] [Related]
3. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.
Siddiqui IA; Adhami VM; Bharali DJ; Hafeez BB; Asim M; Khwaja SI; Ahmad N; Cui H; Mousa SA; Mukhtar H
Cancer Res; 2009 Mar; 69(5):1712-6. PubMed ID: 19223530
[TBL] [Abstract][Full Text] [Related]
4. Nanochemoprevention by bioactive food components: a perspective.
Siddiqui IA; Mukhtar H
Pharm Res; 2010 Jun; 27(6):1054-60. PubMed ID: 20221894
[TBL] [Abstract][Full Text] [Related]
5. Protonation of epigallocatechin-3-gallate (EGCG) results in massive aggregation and reduced oral bioavailability of EGCG-dispersed selenium nanoparticles.
Wu S; Sun K; Wang X; Wang D; Wan X; Zhang J
J Agric Food Chem; 2013 Jul; 61(30):7268-75. PubMed ID: 23822637
[TBL] [Abstract][Full Text] [Related]
6. Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice.
Zhang J; Wang X; Xu T
Toxicol Sci; 2008 Jan; 101(1):22-31. PubMed ID: 17728283
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA
Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420
[TBL] [Abstract][Full Text] [Related]
8. Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles.
Tyagi N; De R; Begun J; Popat A
Int J Pharm; 2017 Feb; 518(1-2):220-227. PubMed ID: 27988378
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin-3-Gallate Attenuates the Adverse Reactions Triggered by Selenium Nanoparticles without Compromising Their Suppressing Effect on Peritoneal Carcinomatosis in Mice Bearing Hepatocarcinoma 22 Cells.
Ban Q; Chi W; Wang X; Wang S; Hai D; Zhao G; Zhao Q; Granato D; Huang X
Molecules; 2023 May; 28(9):. PubMed ID: 37175313
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-β aggregation and cytotoxicity.
Zhang J; Zhou X; Yu Q; Yang L; Sun D; Zhou Y; Liu J
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8475-87. PubMed ID: 24758520
[TBL] [Abstract][Full Text] [Related]
11. Size effect of elemental selenium nanoparticles (Nano-Se) at supranutritional levels on selenium accumulation and glutathione S-transferase activity.
Peng D; Zhang J; Liu Q; Taylor EW
J Inorg Biochem; 2007 Oct; 101(10):1457-63. PubMed ID: 17664013
[TBL] [Abstract][Full Text] [Related]
12. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase.
Ganther HE
Carcinogenesis; 1999 Sep; 20(9):1657-66. PubMed ID: 10469608
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
Granja A; Pinheiro M; Reis S
Nutrients; 2016 May; 8(5):. PubMed ID: 27213442
[TBL] [Abstract][Full Text] [Related]
14. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.
Siddiqui IA; Bharali DJ; Nihal M; Adhami VM; Khan N; Chamcheu JC; Khan MI; Shabana S; Mousa SA; Mukhtar H
Nanomedicine; 2014 Nov; 10(8):1619-26. PubMed ID: 24965756
[TBL] [Abstract][Full Text] [Related]
15. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
Sanna V; Singh CK; Jashari R; Adhami VM; Chamcheu JC; Rady I; Sechi M; Mukhtar H; Siddiqui IA
Sci Rep; 2017 Feb; 7():41573. PubMed ID: 28145499
[TBL] [Abstract][Full Text] [Related]
16. High-dose sodium selenite toxicity cannot be prevented by the co-administration of pharmacological levels of epigallocatechin-3-gallate which in turn aggravates the toxicity.
Sun K; Wu S; Wang Y; Wan X; Thompson HJ; Zhang J
Food Chem Toxicol; 2013 Feb; 52():36-41. PubMed ID: 23137956
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for cancer chemoprevention by green tea polyphenol EGCG.
Tachibana H
Forum Nutr; 2009; 61():156-169. PubMed ID: 19367120
[TBL] [Abstract][Full Text] [Related]
18. Nano-chemotherapeutic efficacy of (-) -epigallocatechin 3-gallate mediating apoptosis in A549 cells: Involvement of reactive oxygen species mediated Nrf2/Keap1signaling.
Velavan B; Divya T; Sureshkumar A; Sudhandiran G
Biochem Biophys Res Commun; 2018 Sep; 503(3):1723-1731. PubMed ID: 30075845
[TBL] [Abstract][Full Text] [Related]
19. Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (-)-epigallocatechin-3-gallate.
Hu B; Ting Y; Zeng X; Huang Q
J Agric Food Chem; 2013 Jan; 61(4):875-81. PubMed ID: 23293838
[TBL] [Abstract][Full Text] [Related]
20. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
